VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 134 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $901,983 | +82.0% | 69,330 | +144.9% | 0.00% | – |
Q1 2024 | $495,690 | +50.1% | 28,309 | +86.7% | 0.00% | – |
Q4 2023 | $330,206 | +42.0% | 15,161 | 0.0% | 0.00% | – |
Q3 2023 | $232,570 | -61.3% | 15,161 | -35.8% | 0.00% | – |
Q2 2023 | $600,918 | 0.0% | 23,621 | 0.0% | 0.00% | – |
Q1 2023 | $600,918 | +5.7% | 23,621 | +21.3% | 0.00% | – |
Q4 2022 | $568,719 | – | 19,470 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 1,314,000 | $15,203,000 | 6.46% |
Ally Bridge Group (NY) LLC | 496,012 | $5,739,000 | 5.23% |
VR Adviser, LLC | 1,852,919 | $21,438,000 | 4.22% |
COMMODORE CAPITAL LP | 1,638,609 | $18,959,000 | 4.01% |
Ghost Tree Capital, LLC | 600,000 | $6,942,000 | 3.62% |
Paradigm Biocapital Advisors LP | 1,306,569 | $15,117,000 | 3.01% |
Fairmount Funds Management LLC | 944,092 | $10,923,000 | 2.50% |
Kynam Capital Management, LP | 590,143 | $6,828,000 | 1.74% |
Soleus Capital Management, L.P. | 841,018 | $9,731,000 | 1.52% |
Vivo Capital, LLC | 1,300,000 | $15,041,000 | 1.51% |